Challenge To FTC Authority Belongs In Calif., Agency Says

Law360, Fort Wayne (March 2, 2017, 3:49 PM EST) -- The U.S. Federal Trade Commission on Thursday asked a Pennsylvania federal court to dismiss a lawsuit by Watson Laboratories and Allergan challenging its authority to bring lawsuits over past behavior, saying the companies should raise the objection in an ongoing pay-for-delay case in California.

The FTC has sued Watson Laboratories Inc. and former parent Allergan Finance LLC in a California federal court alleging the companies delayed generic competition for pain relief patch Lidoderm, and the companies should move to dismiss that case if they believe the agency has stepped outside of its bounds, the FTC said.

Instead, Watson and Allergan have...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!